Evidences for policy making and decision related to the cost of delivering tuberculosis (TB) control is lacking in Ethiopia. The investigators aimed to determine the cost and cost-effectiveness of involving health extension workers (HEWs) in TB treatment under the community-based initiative in Ethiopia.
Two treatment options were compared - health facility and community DOT. In 1995, Ethiopia adopted World Health Organization (WHO) recommended DOTS strategy for TB control. The treatment regimen for new smear-positive patients includes two months of ethambutol, rifampicin, isoniazid and pyrazinamide followed by six months of ethambutol and isoniazid. For children the continuation phase treatment was replaced by four months of rifampicin and isoniazid. Follow up sputum examinations were conducted at the end of 2, 5 and 7 months treatment.
Study Type
OBSERVATIONAL
Enrollment
229
Directly observed treatment (DOT) by health extension workers (HEWs)
YAHC
Irgalem, Snnpr, Ethiopia
cost per successfully treated smear-positive case
Time frame: September 2006 to April 2008
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.